Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Glad you disagree with Ashkan too. Which means you agree with me. Thanks.
Talk to Ashkan or his co-author. I literally linked to it. The quote is from 2023 so it's his recent view.
So you are attacking him and agreeing with me.
About time. And if that was somehow an attack on me, just proves your bias is as bad as your ability to pick a stock.
That's the same guy who co-authored this 2023 paper (after the JAMA DCVax article) Novel therapeutic strategies in glioma targeting glutamatergic neurotransmission
which clearly stated w/regard to Optune:
Has anyone seen Cofer Black since he's been on the board collecting a check? Maybe he dropped a couple LBs? It's probably his soft food diet and extra fiber though.
Sounds good. Get a bunch of pats on the back and thumbs up for shills that made the poorest investment decision as you have, and give crap emojis to those who actually have a clue.
I can go away tomorrow and the stock will still founder on the OTC while you idiots await the MHRA rejection and LP hopes the news isn't so bad that she can't still dump shares while building out Advent for herself.
Thanks for the list of experts who will point out that the endpoint changes were post-hoc, the ECA wasn't properly matched or predefined and there is no patient level data when they reject the submission.
So the gold standard for clinical trials, an RCT is no good says a guy who got laughed off of this message board because he’s an idiot. Still an idiot on Twitter.
The foot doctor has never run a clinical trial either. Even on feet.
Already said I made money on this turd when it wasn’t on the OTC. Easy to make money on a stock that is clearly a P&D.
Yet no longs here seem to want to make money so they hold this until they die since it will never be approved.
Nothing wrong about it. CRSPR was approved in 2023. They filed with both MHRA and FDA because they weren’t dead ass broke like NWBO. My link clearly states the process for 2024 which is the year in which DCvax would be approved if it did anything. But it doesn’t so moot point.
Because the Adcom would bring up the change in trial after everyone was already treated , illegitimate control arm, problems with the blended data at interim vs final data, and all the other issues oncologists and bears have brought up in comments about the JAMA article.
Adcom won’t be made up of company shills that don’t even understand trials.
He’s also chair of the Apple Sauce For Lunch Committee.
Flipper has watched it 14 times.
I think you meant Monty Python because they will need to run trials for every indication just like everyone else.
They can’t even prove it works on the indication for which they ran the trial.
The FDA doesn't care what happens with the MHRA. DCVax wouldn't make it through an FDA Adcom if it is ever submitted.
If the goal was to get it approved worldwide, submitting to MHRA first makes no sense, regardless of them trying to get it approved via the "swift approval process".
If they thought the FDA would approve it based on the P3 the company would have submitted to the FDA first and then approval from MHRA would be near automatic:
Don't compare a company running a 15 year trial with no approvals to one that is actually teaming with Merck to make the vaccine and sharing 50-50 in the profit and has actually brought vaccines to market. Yes the one that matters via the FDA.
15 years of theories on DCVax and they still can't run a legit well designed trial and submit to the only RA that counts, the FDA.. The dog and pony show with MHRA is what companies without a chance of submitting to the FDA do while they fleece shareholders into financing their personal CDMOs.
That's the 15 year excuse for why this POS has lost 98% value. Total BS. There's no NDA involving anything about this company.
Jesus how many times do you idiots pick out some word in some useless PR and claim it is a hint or a clue (aimed at only the elite NWBO shareholders) just for nothing to come of it?
Like almost every PR.
Macebo?
Nobody is manipulating a penny stock turd that trades 1.6 million shares a day except the company when they PR useless BS and stay silent on shit that matters.
Just think how rich you would be if you magically bought this POS at $0.15 like every long claims! Not a single long bought the stock when all those cheapies were available in the $8-12 range back when Woodford was dumping his $100 mill into it.
And you were taking the PBJs your mom made you for school lunch and led a bunch of sheep around eating the bread crumbs while walking in circles.
And you had made as much money on NWBO then as you have now.
Well if you believe that BS you should attend the next ASM if they ever have one and swing by the pedo pizza joint in DC where the celebs are eating baby brains.
QANON much?
Obviously weed is legal from wherever you are posting to write that garbage. Must be Doc's Fantasy Island.
Flaskworks is closer to helping produce strong french fries than it is a strong franchise. Still no comparability study.
NWBO Shills: "It's got nothing on our shelved, zero ORR attempt at treating solid tumors that hasn't seen the light of day since 2016"
They have a patent for a procedure that would require them to design and run a successful trial, which they have yet to do.
And Motorola has a patent for a flip phone. Yay!
Well they aren’t gonna find anyone else outside IHub to say anything positive about this POS.
Good for you. Now buy more cheapies. There are always more cheapies. Then you too can have a big red mark in paper because you will never sell. Sorta like how Doc Logic hasn’t made a cent aside from what he gets paid for being a mod.
1) wrong
2) wrong
3) wrong
4) wrong
5) wrong
Your #2 contradicts 1.
3 is babbling nonsense.
4) They knew it failed even though they werent unblinded.
5). ECA needs to be defined prior to the trial being run. Plenty of links to confirm.
Why don’t you go away you shill.
The trial isn’t about rGBM and you can’t make shit up after the actual trial fails to throw shit at a wall to see if it sticks.
They can’t cry about pseudoprogression messing up the trial then try and claim it didn’t affect rGBM
Says the woman who recommended friends and family buy this piece of crap when she had zero investing experience so she had to make this MB her life to validate her poor advice.
The data shows 13% 5 year survival, dipshit.
The majority of participants in the P3, who are deceased, are disagreeing from the grave.
Such bullshit. Given my experience with P&D scams, the Swiss approval was certainly a P&D scam.
Perhaps your perception of the pumpy BS the company and shills put out is wrong?
The company saying how great the results are then trying to show it by completely changing the protocol of the trial is only great news to those who don't understand how trials work. Plenty of links have been provided showing how poor the new protocol is and the impossibility of it passing muster at the FDA.
The new 2021 tote bags have just arrived!